LINK

Business Context and Reporting Period

Company: Interlink Electronics, Inc. (LINK)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: A global sensor and printed electronics company operating in two divisions: force/touch sensors and gas/environmental sensors. The company designs, develops, and manufactures products for consumer electronics, automotive, industrial, and medical markets. Operations are headquartered in Irvine, California, with manufacturing and R&D facilities in China, Scotland, Singapore, and the U.S.

Key Financial Metrics

Note: All share and per-share data have been retroactively adjusted for a 50% common stock dividend paid in March 2024.

Material Changes vs. Prior Period

• Revenue Decline: Q2 2024 revenue decreased 28.4% year-over-year (YoY) to $2.9 million. YTD revenue decreased 17.8% to $6.0 million. The decline was driven by lower demand in the medical, industrial, and consumer markets for custom products, partially offset by a 3.1% increase in standard product sales.
• Margin Compression: Gross margin declined from 50.9% in Q2 2023 to 45.0% in Q2 2024, attributed to lower revenues and changes in product/customer mix.
• Operating Expenses: Total operating expenses remained relatively flat in Q2 ($1.6M vs $1.7M), but Selling, General, and Administrative (SG&A) expenses increased 10.2% YoY due to higher intangible asset amortization from the Calman acquisition. R&D expenses decreased 21.5% due to lower compensation costs.
• Profitability: The company reported a net loss of $307,000 in Q2 2024 compared to a net income of $381,000 in Q2 2023. The shift to a loss was driven by the revenue decline and increased amortization expenses.
• Cash Flow: Net cash used in operating activities improved significantly to $(76,000) for the six months ended June 30, 2024, compared to $(245,000) in the prior year period, largely due to a $684,000 decrease in accounts receivable.

Guidance, Outlook, and Risks

• Outlook: Management believes existing cash balances ($4.0 million) are sufficient to maintain current operations. No specific financial guidance was provided in the filing.
• Preferred Stock Obligations: The company has 200,000 shares of 8.0% Series A Convertible Preferred Stock outstanding with a $5.0 million liquidation preference. Monthly cumulative cash dividends are paid, totaling $200,000 for the six months ended June 30, 2024.
• Risks and Contingencies:
  • Customer Concentration: Two customers accounted for 27% and 15% of total accounts receivable as of June 30, 2024. Customer A represented 24% of Q2 revenue.
  • Related Party Transactions: Significant facilities and consulting agreements exist with Qualstar Corporation and BKF Capital Group, Inc., entities controlled by the company's CEO.
  • Supply Chain: Ongoing risks related to global supply chain constraints and foreign currency fluctuations (functional currencies include Renminbi and British Pound).
  • Lease Liabilities: Significant increase in lease liabilities due to new and renewed facilities in California, China, and Scotland. Total lease liabilities increased from $159,000 at year-end 2023 to $851,000 at June 30, 2024.

Investor Verification Checklist

• Revenue Sustainability: Verify the reasons for the 28% Q2 revenue drop and the specific impact of the decline in medical and industrial custom product sales.
• Amortization Impact: Assess the long-term impact of increased intangible asset amortization (from the Calman acquisition) on future operating margins.
• Liquidity Runway: Confirm the sufficiency of the $4.0 million cash balance given the recurring $200,000 semi-annual preferred dividend obligation and operating losses.
• Lease Commitments: Review the future minimum lease payments totaling $1.0 million over the next several years and the impact on cash flow.
• Customer Concentration: Evaluate the risk associated with the top two customers representing 42% of accounts receivable.